Managing postoperative clinical recurrence of Crohn's disease: is it time to shift our paradigm?

Affiliations

Comment

Jonathan S Levine. Inflamm Bowel Dis. 2012 Jan.

. 2012 Jan;18(1):194-5.

doi: 10.1002/ibd.21759. Epub 2011 May 20.

¹ Division of Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

No abstract available

Comment on

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group. Reinisch W, et al. Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159. Gut. 2010. PMID: 20551460 Clinical Trial.